Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha

Journal of Bone and Mineral Metabolism

Volumn 31, Issue 6, 2013, Pages 618-628

  Hamamura, Kazunori ^a   Tanjung, Nancy ^a   Yokota, Hiroki ^a,b  

^a Indiana University Purdue University Indianapolis   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

eIF2 ; Guanabenz; NFATc1; Osteoclasts; Salubrinal

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACTIVATING TRANSCRIPTION FACTOR 4; GUANABENZ; INITIATION FACTOR 2ALPHA; MEMBRANE RECEPTOR; NUCLEAR FACTOR OF ACTIVATED T CELLS C1; OSTEOCLAST ASSOCIATED RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; RNA; SALUBRINAL; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; ENZYME REPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; UPREGULATION;

ACID PHOSPHATASE; ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; CELLS, CULTURED; CINNAMATES; DOWN-REGULATION; EUKARYOTIC INITIATION FACTOR-2; GENES, FOS; GUANABENZ; ISOENZYMES; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; RNA, MESSENGER; THIOUREA;

EID: 84887996948     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-013-0450-0     Document Type: Article

References (35)

1. Karsenty G, Wagner EF (2002) Reaching a genetic and molecular understanding of skeletal development. Cell 2:389-406
2. Harada S, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423:349-355
3. Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
4. Kimball SC (1999) Eukaryotic initiation factor eIF2. Int J Biochem 31:25-39
5. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6:1099-1108
6. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117:387-398
7. Hamamura K, Yokota H (2007) Stress to endoplasmic reticulum of mouse osteoblasts induces apoptosis and transcriptional activation for bone remodeling. FEBS Lett 581:1769-1774
8. Zhang P, Hamamura K, Jiang C, Zhao L, Yokota H (2012) Salubrinal promotes healing of surgical wounds in rat femurs. J Bone Miner Metab 30:568-579
9. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, et al. (1988) Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602
10. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
11. Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283:5866-5875
12. Zhang P, Jiang C, Ledet E, Yokota H (2011) Loading- and unloading-driven regulation of phosphorylation of eIF2α. Biol Sci Space 25:3-6
13. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D, Yuan J (2005) A selective inhibitor of eIF2α dephosphorylation protects cells from ER stress. Science 307:935-939
14. Tsaytler P, Harding HP, Ron D, Bertolotti A (2011) Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 332:91-94
15. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487
16. Furuya Y, Mori K, Ninomiya T, Tomimori Y, Tanaka S, Takahashi N, Udagawa N, Uchida K, Yasuda H (2011) Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-κB ligand-neutralizing antibody. J Biol Chem 286:37023-37031
17. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S (1983) In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191-198
18. Xu J, Tan JW, Gao XH, Laird R, Liu D, Wysocki S, Zheng MH (2000) Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand. J Bone Miner Res 15:2178-2186
19. Wagner EF, Matsuo K (2003) Signaling in osteoclasts and the role of Fos/AP1 proteins. Ann Rheum Dis 62:ii83-ii85
20. Helfrich MH, Thesingh CW, Mieremet RH, van Iperen-van Gent AS (1987) Osteoclast generation from human fetal bone marrow in cocultures with murine fetal long bones. A model for in vitro study of human osteoclast formation and function. Cell Tissue Res 249:125-136
21. Kim N, Takami M, Rho J, Josien R, Choi Y (2002) A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med 195:201-209
22. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901
23. Hamamura K, Zhang P, Yokota H (2008) IGF2-driven PI3 kinase and TGFβ signaling pathways in chondrogenesis. Cell Biol Int 32:1238-1246
24. Shah RS, Walker BR, Vanov SK, Helfant RH (1976) Guanabenz effects on blood pressure and noninvasive parameters of cardiac performance in patients with hypertension. Clin Pharmacol Ther 19:732-737
25. Galli M, Caniggia M (1984) Osteocalcin. Minerva Med 75:2489-2501
26. Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA (2000) Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increase rate of bone turnover. J Bone Miner Res 15:103-110
27. Wang S, Kaufman RJ (2012) The impact of the unfolded protein response on human disease. J Cell Biol 197:857-867
28. Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M (2000) Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappaB ligand (RANKL). J Biol Chem 275:31155-31161
29. Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y (2001) Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 276:563-568
30. Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, Lee SY, Kim N (2007) MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109:3253-3259
31. Zhao B, Takami M, Yamada A, Wang X, Koga T, Hu X, Tamura T, Ozato K, Choi Y, Ivashkiv LB, Takayanagi H, Kamijo R (2009) Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med 15:1066-1071
32. Miyauchi Y, Ninomiya K, Miyamoto H, Sakamoto A, Iwasaki R et al (2010) The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J Exp Med 207:751-762
33. Rossi M, Pitari MR, Amodio N, Di Martino MT, Conforti F, Leone E, Botta C, Paolino FM, Del Giudice T, Iuliano E, Caraglia M, Ferrarini M, Giordano A, Tagliaferri P, Tassone P (2012) miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. J Cell Physiol (in press)
34. Yasui T, Hirose J, Tsutsumi S, Nakamura K, Aburatani H, Tanaka S (2011) Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J Bone Miner Res 26:2655-2671
35. He L, Lee J, Jang JH, Sakchaisri K, Hwang JS, Cha-Molstad HJ, Kim KA, Ryoo IJ, Lee HG, Kim SO, Soung NK, Lee KS, Kwon YT, Erikson RL, Ahn JS, Kim BY (2013) Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast. Cell Signal 25:552-560